---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-090197"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2025-09-22T23:59:59+00:00"
generated_at: "2026-05-17T06:00:24.167959+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics raises ~$2.5M in private placement, with option for additional $7.5M

## Summary
- Sold 1,562,500 shares at $1.60/sh and/or pre-funded warrants at $1.5999 for gross proceeds ~$2.5M.
- Initial closing scheduled for Sept 23, 2025, subject to customary closing conditions.
- Investor has 90-day option to purchase additional shares/warrants for up to $7.5M at then-current minimum price.
- Shares and warrants issued in private placement under Section 4(a)(2); registration rights agreement filed.

## SEC filing metadata
- accession: 0001213900-25-090197
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2025-09-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390025090197/0001213900-25-090197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390025090197/ea0258310-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-090197
- JSON: https://secwatch.observer/filing/0001213900-25-090197.json
- Plain text: https://secwatch.observer/filing/0001213900-25-090197.txt

## Key facts
- Equity Issuances
  Allarity Therapeutics, Inc. issued warrant to a certain accredited investor for $0.0001 exercise price per Pre-Funded Warrant; purchase price $1.5999 per Pre-Funded Warrant.
  - Security: warrant
  - Purchaser: a certain accredited investor
  - Consideration: $0.0001 exercise price per Pre-Funded Warrant; purchase price $1.5999 per Pre-Funded Warrant
  source text: the Company has agreed to issue and sell 1,562,500 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) for $1.60 per Share, and/or pre-funded warrants in (the “Pre-Funded Warrants) to purchase one share of Common Stock per Pre-Funded Warrant, at an offering price of $1.5999 per Pre-Funded Warrant (the “Purchase Price”), for gross proceeds to the Company of approximately $2.5 million, before deducting fees and expenses.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390025090197/0001213900-25-090197-index.htm
- Equity Issuances
  Allarity Therapeutics, Inc. issued 1,562,500 shares of common stock to a certain accredited investor for $1.60 per Share, for gross proceeds of approximately $2.5 million.
  - Security: common stock
  - Shares: 1,562,500 shares
  - Purchaser: a certain accredited investor
  - Consideration: $1.60 per Share, for gross proceeds of approximately $2.5 million
  source text: the Initial Closing, the Company has agreed to issue and sell 1,562,500 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) for $1.60 per Share, and/or pre-funded warrants in (the “Pre-Funded Warrants) to purchase one share of Common Stock per Pre-Funded Warrant, at an offering price of $1.5999 per Pre-Funded
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390025090197/0001213900-25-090197-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.